The latest prostate cancer news
Researchers develop model to predict prostate cancer aggressiveness
Prostate cancer is the most common cancer in men. One in nine men will be…
Browsing: Prostate Cancer
ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer
It has been announced that the results from the final analysis of the pivotal Phase…
ASCO 2020: New class of targeted radioactive treatment effective for men with metastatic prostate cancer
The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) reports the interim…
Novel radiotracer meets gold standard for imaging prostate cancer
The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting malignant prostate cancer…
Androgen-deprivation treatments for prostate cancer could protect men from COVID-19
A study of 4532 men in the Veneto region of Italy has found that those…
Approval of targeted therapies first line for prostate cancer ‘will ease Covid-19 pressures’
The Institute of Cancer Research, London, UK, has broadly welcomed the approval of targeted hormone…
First patient enrolled in Sydney in worldwide prostate cancer trial
The first of 1,100 patients has been enrolled on a new cancer trial for treatment…
Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective…
New clues about why some metastatic prostate cancers don’t respond to enzalutamide
Over the last decade, enzalutamide and similar drugs have led to significant tumour control and…
Immune system could be key to reducing the growth of prostate cancer spread to the bone
A new approach to prostate cancer treatment increases the visibility of prostate cancer cells that…